Expression and Clinical Significance of ADAM 19 in Endometrial Carcinoma

Qinping Liao
2008-01-01
Abstract:Objective: To investigate the expression of adamalysin19 (ADAM19) in human endometrial carcinoma and to explore its correlation with clinical behavio r and pathological characters. Methods: Immunohistochemistry w as conducted to de tect the expression of ADAM19 in the endometrial tissue from 51 patients with en dometrial carcinoma and 33 patients with normal endometrium.The results were ana lyzed with clinical data.Results:Postive expression signals of ADAM19 were detected both in the endome-trial cancer tissue and normal endometrium. The expression level of ADAM19 in endometrial cancer ti ssue was significantly higher than that in normal endometrium (P0.001).Tho se w ith lower histological grade or non-adenocarcinoma had a higher expression level(P =0. 028 , P=0.042). In addition, ADAM19 in thecarcinoma with myometrial invasion had a higher expression trend than that without myometrial invasion (P=0.065). Howe ver, from the clinical data we found no correlation with surgical staging and me tastasis of lymph nodes(P=0.328, P=0.529). Conclusion: The overexpression of ADAM 19 suggests that ADAM19 correlates with the progress and prognosis of endometria l carcinoma, and may be implicated as a marker for the clinical behavior of endo metrial carcinoma.
What problem does this paper attempt to address?